Dermatol. praxi. 2020;14(4):188-192 | DOI: 10.36290/der.2020.035

Dry skin: possible causes and everyday care options

MUDr. Naděžda Vojáčková
Dermatologické centrum Anděl, Praha

Dry skin, also referred to as xerosis cutis, xerosis, or asteatosis, is a common dermatological-cosmetic problem. It depends on the cause and symptom severity. A physiologically dry skin occurs in newborns, infants, toddlers, and the elderly. Extrinsic factors related to atopic eczema, psoriasis, or ichthyosis have an effect on skin dryness. Dry skin may be a manifestation of internal disease or a result of medication use. It affects individuals of different ages at various parts of the body. The causes may be both exogenous and endogenous factors as well as their combination. Several factors underlie the changes: factors interfering with skin barrier integrity; changes in the corneal layer; abnormalities in keratinization; changes in the composition of intercellular lipids and changes in the hydrolipidic film; impaired water metabolism; and a shift in skin pH. In all types of xerosis, there is a problem in keratinization and lipid metabolism. Between 20 and 50 percent of the population are estimated to suffer from a varying degree of dry skin.

Keywords: dry skin, xerosis, barrier function, emollients.

Published: November 20, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vojáčková N. Dry skin: possible causes and everyday care options. Dermatol. praxi. 2020;14(4):188-192. doi: 10.36290/der.2020.035.
Download citation

References

  1. Augustin M, Wilsmann‑Thes D, Körber A. Diagnosis and treatment of xerosis cutis - a position paper. JDDG 2019; 17(7): 3-33. Go to original source... Go to PubMed...
  2. Pons‑Guiraud A. Dry skin in dermatology: a complex physiopathology. JEADV 2007; 21(2): 1-4. Go to original source...
  3. Linde SW. Dry skin in atopic dermatitis. Acta Derm Venerol 1992; 177: 9-13. Go to original source...
  4. Obstová I, Iličová S. Každodenní péče o suchou pokožku. Med pro praxi. 2007; 7: 68-75.
  5. Augustin M, Kirsten N, Körber A, et al. Prevalence, predictors and comorbidity of dry skin in the general population. JEADV 2018; 33 (1): 147-150. Go to original source... Go to PubMed...
  6. Proksch E, Lachapelle JM. The management of dry skin with topical emollients - recent perspectives. JDDG 2005; 3: 768-774. Go to original source... Go to PubMed...
  7. Weber TM, Kausch M, Rippke F, et al. Treatment of xerosis with a topical formulation containing glyceryl glucoside, natural moisturizing factors and ceramides. J Clin Aesthet Dermatol 2012; 5(8): 29-39.
  8. Boralevi F, Saint Aroman M, Delarue A, et al. Long‑term emollient therapy improves xerosis in children with atopic dermatitis. JEADV 2014; 28: 1456-1462. Go to original source... Go to PubMed...
  9. Lebwohl M, Herrmann LG. Impaired skin barrier function in dermatologic disease and repair with moisturization. Cutis 2005; 76(6): 7-12. Go to PubMed...
  10. Choi MJ, Maibach HI. Role of ceramides in barrier function of healthy and diseased skin. AM J Clin Dermtol 2005, 6(4): 215-223. Go to original source... Go to PubMed...
  11. Drahutská Z. Postavení emoliencií v současné léčbě atopické dermatitidy. Dermatol. praxi 2017, 11(3): 120-125. Go to original source...
  12. Sklenář Z, et al. Magistraliter receptura v dermatologii. Praha: Galén 2009.
  13. Sklenář Z. Nová emoliencia s obsahem močoviny v magistraliter přípravcích. Čes‑slov Derm 2010; 85(5): 274-279. Go to original source...
  14. Lindh JD, Bradley M. Clinical effectivness of moisturizers in atopic dermatitis and related disorders: a systematic rewiev. Am J Clin Dermatol 2015; 16(5): 341-359. Go to original source... Go to PubMed...
  15. Meckfessel MH, Brandt S. The structure, function and importance of ceramides in skin and their use as therapeutic agents in skin‑care products. J Am Acad Dermatol 2014; 71(1): 177-184. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.